EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1

PLoS Pathogens

Volumn 12, Issue 1, 2016, Pages

  Lu, Fang ^a   Chen, Horng Shen ^a   Kossenkov, Andrew V ^a   DeWispeleare, Karen ^a   Won, Kyoung Jae ^b   Lieberman, Paul M ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 2; EXTRACHROMOSOMAL DNA; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EBF1; UNCLASSIFIED DRUG; EBF1 PROTEIN, HUMAN; EBNA-2 PROTEIN, HUMAN HERPESVIRUS 4; EPSTEIN BARR VIRUS ANTIGEN; RBPJ PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; VIRAL PROTEIN;

ARTICLE; BIOCHEMICAL ANALYSIS; CELL GROWTH; CELL VIABILITY ASSAY; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME BINDING SITE; CHROMOSOME STRUCTURE; DNA DETERMINATION; DNA MICROARRAY; GENETIC ANALYSIS; GENOME ANALYSIS; HIGH THROUGHPUT SEQUENCING; LYMPHOBLAST; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; TRANSCRIPTION INITIATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; B LYMPHOCYTE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; VIROLOGY; VIRUS CELL TRANSFORMATION;

B-LYMPHOCYTES; BLOTTING, WESTERN; CELL TRANSFORMATION, VIRAL; CHROMATIN IMMUNOPRECIPITATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 84956827927     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005339     Document Type: Article

References (50)

1. Longnecker R, Kieff E, Cohen JI, Knipe DM, Howley PM, Epstein-Barr Virus. In: Fields Virology. I. 6th ed. Philadelphia: Lipincott; 2013. p. 1898–959.
2. Young LS, Rickinson AB, Epstein-Barr virus: 40 years on. Nature reviews Cancer. 2004;4(10):757–68. 15510157
3. Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M, The pathogenesis of Epstein-Barr virus persistent infection. Current opinion in virology. 2013;3(3):227–32. doi: 10.1016/j.coviro.2013.04.005 23683686
4. Raab-Traub N, Novel mechanisms of EBV-induced oncogenesis. Current opinion in virology. 2012;2(4):453–8. doi: 10.1016/j.coviro.2012.07.001 22858118
5. Thorley-Lawson DA, Epstein-Barr virus: exploiting the immune system. Nature reviews Immunology. 2001;1(1):75–82. 11905817
6. Kang MS, Kieff E, Epstein-Barr virus latent genes. Experimental & molecular medicine. 2015;47:e131.
7. Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD, Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Molecular and cellular biology. 1996;16(3):952–9. 8622698
8. Strobl LJ, Hofelmayr H, Stein C, Marschall G, Brielmeier M, Laux G, et al. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa. Immunobiology. 1997;198(1–3):299–306. 9442401
9. Hayward SD, Liu J, Fujimuro M, Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses. Science's STKE: signal transduction knowledge environment. 2006;2006(335):re4. 16705130
10. Hayward SD, Viral interactions with the Notch pathway. Seminars in cancer biology. 2004;14(5):387–96. 15288264
11. Borggrefe T, Oswald F, The Notch signaling pathway: transcriptional regulation at Notch target genes. Cellular and molecular life sciences: CMLS. 2009;66(10):1631–46. doi: 10.1007/s00018-009-8668-7 19165418
12. Portal D, Zhou H, Zhao B, Kharchenko PV, Lowry E, Wong L, et al. Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(46):18537–42. doi: 10.1073/pnas.1317608110 24167291
13. Boller S, Grosschedl R, The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function. Immunological reviews. 2014;261(1):102–15. doi: 10.1111/imr.12206 25123279
14. Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K, Liang J, et al. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell host & microbe. 2015;17(2):205–16.
15. Iwafuchi-Doi M, Zaret KS, Pioneer transcription factors in cell reprogramming. Genes & development. 2014;28(24):2679–92.
16. Rothenberg EV, Transcriptional control of early T and B cell developmental choices. Annual review of immunology. 2014;32:283–321. doi: 10.1146/annurev-immunol-032712-100024 24471430
17. Tempera I, Klichinsky M, Lieberman PM, EBV latency types adopt alternative chromatin conformations. PLoS pathogens. 2011;7(7):e1002180. doi: 10.1371/journal.ppat.1002180 21829357
18. Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, et al. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(36):14902–7. doi: 10.1073/pnas.1108892108 21746931
19. McClellan MJ, Wood CD, Ojeniyi O, Cooper TJ, Kanhere A, Arvey A, et al. Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming. PLoS pathogens. 2013;9(9):e1003636. doi: 10.1371/journal.ppat.1003636 24068937
20. Jiang S, Willox B, Zhou H, Holthaus AM, Wang A, Shi TT, et al. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(1):421–6. doi: 10.1073/pnas.1321704111 24344258
21. Consortium EP, Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74. Epub 2012/09/08. doi: 10.1038/nature11247 22955616
22. Calo E, Wysocka J, Modification of enhancer chromatin: what, how, and why? Molecular cell. 2013;49(5):825–37. doi: 10.1016/j.molcel.2013.01.038 23473601
23. Kempkes B, Spitkovsky D, Jansen-Durr P, Ellwart JW, Kremmer E, Delecluse HJ, et al. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. The EMBO journal. 1995;14(1):88–96. 7828599
24. Tempera I, Lieberman PM, Epigenetic regulation of EBV persistence and oncogenesis. Seminars in cancer biology. 2014;26:22–9. doi: 10.1016/j.semcancer.2014.01.003 24468737
25. Trivedi P, Spinsanti P, Cuomo L, Volpe M, Takada K, Frati L, et al. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain. Journal of virology. 2001;75(10):4929–35. 11312367
26. Wang H, Zou J, Zhao B, Johannsen E, Ashworth T, Wong H, et al. Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(36):14908–13. doi: 10.1073/pnas.1109023108 21737748
27. Schmidt SC, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, et al. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Proceedings of the National Academy of Sciences of the United States of America. 2015;112(2):554–9. doi: 10.1073/pnas.1422580112 25540416
28. Harth-Hertle ML, Scholz BA, Erhard F, Glaser LV, Dolken L, Zimmer R, et al. Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS pathogens. 2013;9(9):e1003638. doi: 10.1371/journal.ppat.1003638 24068939
29. Tzellos S, Correia PB, Karstegl CE, Cancian L, Cano-Flanagan J, McClellan MJ, et al. A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2. Journal of virology. 2014;88(16):8743–53. doi: 10.1128/JVI.01000-14 24850736
30. Ohashi M, Holthaus AM, Calderwood MA, Lai CY, Krastins B, Sarracino D, et al. The EBNA3 Family of Epstein-Barr Virus Nuclear Proteins Associates with the USP46/USP12 Deubiquitination Complexes to Regulate Lymphoblastoid Cell Line Growth. PLoS pathogens. 2015;11(4):e1004822. doi: 10.1371/journal.ppat.1004822 25855980
31. Miele L, Transcription factor RBPJ/CSL: a genome-wide look at transcriptional regulation. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(36):14715–6. doi: 10.1073/pnas.1110570108 21873209
32. Yashiro-Ohtani Y, Wang H, Zang C, Arnett KL, Bailis W, Ho Y, et al. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(46):E4946–53. doi: 10.1073/pnas.1407079111 25369933
33. Wang H, Zang C, Taing L, Arnett KL, Wong YJ, Pear WS, et al. NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(2):705–10. doi: 10.1073/pnas.1315023111 24374627
34. Castel D, Mourikis P, Bartels SJ, Brinkman AB, Tajbakhsh S, Stunnenberg HG, Dynamic binding of RBPJ is determined by Notch signaling status. Genes & development. 2013;27(9):1059–71.
35. Rowe M, Raithatha S, Shannon-Lowe C, Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions. Journal of virology. 2014;88(20):12065–76. doi: 10.1128/JVI.01431-14 25122803
36. Treiber T, Mandel EM, Pott S, Gyory I, Firner S, Liu ET, et al. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. Immunity. 2010;32(5):714–25. doi: 10.1016/j.immuni.2010.04.013 20451411
37. Gyory I, Boller S, Nechanitzky R, Mandel E, Pott S, Liu E, et al. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes & development. 2012;26(7):668–82.
38. Guilhamon P, Eskandarpour M, Halai D, Wilson GA, Feber A, Teschendorff AE, et al. Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2. Nature communications. 2013;4:2166. doi: 10.1038/ncomms3166 23863747
39. Bossen C, Murre CS, Chang AN, Mansson R, Rodewald HR, Murre C, The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth. Nature immunology. 2015.
40. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Molecular cell. 2010;38(4):576–89. doi: 10.1016/j.molcel.2010.05.004 20513432
41. Tanigaki K, Han H, Yamamoto N, Tashiro K, Ikegawa M, Kuroda K, et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nature immunology. 2002;3(5):443–50. 11967543
42. Lee TI, Johnstone SE, Young RA, Chromatin immunoprecipitation and microarray-based analysis of protein location. Nature protocols. 2006;1(2):729–48. 17406303
43. Chau CM, Lieberman PM, Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. Journal of virology. 2004;78(22):12308–19. 15507618
44. Moss T, Leblanc B, DNA-protein interactions principles and protocols. New York: Humana,; 2009. Available from: http://hdl.library.upenn.edu/1017.12/500285 Connect to full text.
45. Lu F, Day L, Gao SJ, Lieberman PM, Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. Journal of virology. 2006;80(11):5273–82. 16699007
46. Atanasiu C, Lezina L, Lieberman PM, DNA affinity purification of Epstein-Barr virus OriP-binding proteins. Methods Mol Biol. 2005;292:267–76. 15507714
47. Deng Z, Wang Z, Stong N, Plasschaert R, Moczan A, Chen HS, et al. A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. The EMBO journal. 2012;31(21):4165–78. doi: 10.1038/emboj.2012.266 23010778
48. Langmead B, Trapnell C, Pop M, Salzberg SL, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome biology. 2009;10(3):R25. Epub 2009/03/06. doi: 10.1186/gb-2009-10-3-r25 19261174
49. The ENCODE Project ConsortiumAn integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74. http://www.nature.com/nature/journal/v489/n7414/abs/nature11247.html-supplementary-information. doi: 10.1038/nature11247 22955616
50. Storey JD, Dai JY, Leek JT, The optimal discovery procedure for large-scale significance testing, with applications to comparative microarray experiments. Biostatistics. 2007;8(2):414–32. 16928955